Prevention and management of immune-related adverse events for biliary tract cancers
Immune checkpoint inhibitors (ICIs) combined with chemotherapy has become the first-line standard treatment for advanced biliary tract cancers (BTC). However, the application of ICIs comes with its risks of immune-related adverse events (irAEs). BTC patients often face greater challenges in the diag...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Chinese |
| Published: |
Editorial Office of Journal of Surgery Concepts & Practice
2025-03-01
|
| Series: | Waike lilun yu shijian |
| Subjects: | |
| Online Access: | https://www.qk.sjtu.edu.cn/jscp/fileup/1007-9610/PDF/1751876439817-1105793041.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|